• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观点:利用肠道微生物群预测饮食、益生元和益生菌干预的个性化反应。

Perspective: Leveraging the Gut Microbiota to Predict Personalized Responses to Dietary, Prebiotic, and Probiotic Interventions.

机构信息

Institute for Systems Biology, Seattle, WA, USA.

Department of Bioengineering, University of Washington, Seattle, WA, USA.

出版信息

Adv Nutr. 2022 Oct 2;13(5):1450-1461. doi: 10.1093/advances/nmac075.

DOI:10.1093/advances/nmac075
PMID:35776947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9526856/
Abstract

Humans often show variable responses to dietary, prebiotic, and probiotic interventions. Emerging evidence indicates that the gut microbiota is a key determinant for this population heterogeneity. Here, we provide an overview of some of the major computational and experimental tools being applied to critical questions of microbiota-mediated personalized nutrition and health. First, we discuss the latest advances in in silico modeling of the microbiota-nutrition-health axis, including the application of statistical, mechanistic, and hybrid artificial intelligence models. Second, we address high-throughput in vitro techniques for assessing interindividual heterogeneity, from ex vivo batch culturing of stool and continuous culturing in anaerobic bioreactors, to more sophisticated organ-on-a-chip models that integrate both host and microbial compartments. Third, we explore in vivo approaches for better understanding of personalized, microbiota-mediated responses to diet, prebiotics, and probiotics, from nonhuman animal models and human observational studies, to human feeding trials and crossover interventions. We highlight examples of existing, consumer-facing precision nutrition platforms that are currently leveraging the gut microbiota. Furthermore, we discuss how the integration of a broader set of the tools and techniques described in this piece can generate the data necessary to support a greater diversity of precision nutrition strategies. Finally, we present a vision of a precision nutrition and healthcare future, which leverages the gut microbiota to design effective, individual-specific interventions.

摘要

人类对饮食、益生元和益生菌干预的反应常常存在差异。新出现的证据表明,肠道微生物群是这种人群异质性的关键决定因素。在这里,我们提供了一些主要的计算和实验工具的概述,这些工具被应用于关键的微生物群介导的个性化营养和健康问题。首先,我们讨论了在微生物群-营养-健康轴的计算模型方面的最新进展,包括统计、机制和混合人工智能模型的应用。其次,我们解决了用于评估个体间异质性的高通量体外技术,从粪便的离体批量培养和厌氧生物反应器中的连续培养,到更复杂的整合宿主和微生物区室的器官芯片模型。第三,我们探讨了更好地理解个性化、微生物群介导的饮食、益生元和益生菌反应的体内方法,从非人类动物模型和人类观察性研究,到人类喂养试验和交叉干预。我们强调了一些现有的、面向消费者的精准营养平台的例子,这些平台目前正在利用肠道微生物群。此外,我们还讨论了如何整合更广泛的工具和技术,以生成支持更多样化精准营养策略所需的数据。最后,我们提出了一个利用肠道微生物群来设计有效、个体特异性干预措施的精准营养和医疗保健的未来愿景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d826/9526856/ca8aca836bd4/nmac075fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d826/9526856/ca8aca836bd4/nmac075fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d826/9526856/ca8aca836bd4/nmac075fig1.jpg

相似文献

1
Perspective: Leveraging the Gut Microbiota to Predict Personalized Responses to Dietary, Prebiotic, and Probiotic Interventions.观点:利用肠道微生物群预测饮食、益生元和益生菌干预的个性化反应。
Adv Nutr. 2022 Oct 2;13(5):1450-1461. doi: 10.1093/advances/nmac075.
2
Prebiotic and Probiotic Modulation of the Microbiota-Gut-Brain Axis in Depression.益生菌和益生元对抑郁症患者的“微生物群-肠道-大脑轴”的调节作用。
Nutrients. 2023 Apr 13;15(8):1880. doi: 10.3390/nu15081880.
3
Microbiome Composition in Pediatric Populations from Birth to Adolescence: Impact of Diet and Prebiotic and Probiotic Interventions.儿科人群从出生到青春期的微生物组组成:饮食以及益生元和益生菌干预的影响。
Dig Dis Sci. 2020 Mar;65(3):706-722. doi: 10.1007/s10620-020-06092-x.
4
Probiotics and prebiotics, targeting obesity with functional foods.益生菌和益生元,以功能性食品为目标的肥胖症。
Bratisl Lek Listy. 2021;122(9):647-652. doi: 10.4149/BLL_2021_104.
5
A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology.一种新型多酚类益生元和益生菌配方对肠道微生物群具有协同作用,影响黑腹果蝇的生理学。
Artif Cells Nanomed Biotechnol. 2018;46(sup2):441-455. doi: 10.1080/21691401.2018.1458731. Epub 2018 Apr 12.
6
Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism.人类肠道微生物共代谢中基于饮食的代谢足迹开发的进展与挑战。
J Nutr. 2015 May;145(5):1123S-1130S. doi: 10.3945/jn.114.194936. Epub 2015 Apr 1.
7
Microbial community-scale metabolic modelling predicts personalized short-chain fatty acid production profiles in the human gut.微生物群落规模代谢建模预测人类肠道中个性化的短链脂肪酸产生谱。
Nat Microbiol. 2024 Jul;9(7):1700-1712. doi: 10.1038/s41564-024-01728-4. Epub 2024 Jun 24.
8
Probiotic, Prebiotic, and Brain Development.益生菌、益生元和大脑发育。
Nutrients. 2017 Nov 14;9(11):1247. doi: 10.3390/nu9111247.
9
Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.益生菌、益生元和饮食对肠道微生物群-大脑轴的调节。
J Agric Food Chem. 2015 Sep 16;63(36):7885-95. doi: 10.1021/acs.jafc.5b02404. Epub 2015 Sep 1.
10
The microbial-mammalian metabolic axis: a critical symbiotic relationship.微生物-哺乳动物代谢轴:一种关键的共生关系。
Curr Opin Clin Nutr Metab Care. 2016 Jul;19(4):250-256. doi: 10.1097/MCO.0000000000000284.

引用本文的文献

1
Integrating Precision Medicine and Digital Health in Personalized Weight Management: The Central Role of Nutrition.将精准医学和数字健康整合到个性化体重管理中:营养的核心作用。
Nutrients. 2025 Aug 20;17(16):2695. doi: 10.3390/nu17162695.
2
Integrated Medical and Digital Approaches to Enhance Post-Bariatric Surgery Care: A Prototype-Based Evaluation of the NutriMonitCare System in a Controlled Setting.综合医学与数字方法以加强减重手术后护理:在可控环境中对NutriMonitCare系统进行基于原型的评估。
Nutrients. 2025 Aug 2;17(15):2542. doi: 10.3390/nu17152542.
3
Boosting Immunity Through Nutrition and Gut Health: A Narrative Review on Managing Allergies and Multimorbidity.

本文引用的文献

1
Heterogeneity in statin responses explained by variation in the human gut microbiome.他汀类药物反应的异质性由人类肠道微生物组的变异解释。
Med. 2022 Jun 10;3(6):388-405.e6. doi: 10.1016/j.medj.2022.04.007. Epub 2022 May 11.
2
Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans.人类特定纤维引起的分子和微生物特征的全球、独特和个体变化。
Cell Host Microbe. 2022 Jun 8;30(6):848-862.e7. doi: 10.1016/j.chom.2022.03.036. Epub 2022 Apr 27.
3
Public human microbiome data are dominated by highly developed countries.
通过营养与肠道健康增强免疫力:关于管理过敏和多种疾病的叙述性综述
Nutrients. 2025 May 15;17(10):1685. doi: 10.3390/nu17101685.
4
Nutraceuticals for Gut-Brain Axis Health: A Novel Approach to Combat Malnutrition and Future Personalised Nutraceutical Interventions.用于肠道-脑轴健康的营养保健品:对抗营养不良的新方法及未来个性化营养保健品干预措施
Nutrients. 2025 Apr 30;17(9):1551. doi: 10.3390/nu17091551.
5
Gut microbiota-derived short-chain fatty acids and their role in human health and disease.肠道微生物群衍生的短链脂肪酸及其在人类健康与疾病中的作用。
Nat Rev Microbiol. 2025 May 13. doi: 10.1038/s41579-025-01183-w.
6
Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19.新型冠状病毒感染中的微生物群失调:对2019冠状病毒病病理生理学和管理策略的影响
Front Cell Infect Microbiol. 2025 Apr 22;15:1537456. doi: 10.3389/fcimb.2025.1537456. eCollection 2025.
7
Metagenomic estimation of dietary intake from human stool.基于宏基因组学的人体粪便饮食摄入量估算。
Nat Metab. 2025 Mar;7(3):617-630. doi: 10.1038/s42255-025-01220-1. Epub 2025 Feb 18.
8
Prebiotics Beyond the Gut: Omics Insights, Artificial Intelligence, and Clinical Trials in Organ-Specific Applications.肠道之外的益生元:组学见解、人工智能及器官特异性应用中的临床试验
Probiotics Antimicrob Proteins. 2025 Jan 29. doi: 10.1007/s12602-025-10465-x.
9
Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health.益生菌与食物生物活性成分:揭示它们对肠道微生物群、炎症和代谢健康的影响
Probiotics Antimicrob Proteins. 2025 Jan 14. doi: 10.1007/s12602-025-10452-2.
10
Metabolic modelling uncovers the complex interplay between fungal probiotics, poultry microbiomes, and diet.代谢建模揭示了真菌益生菌、家禽微生物群和饮食之间的复杂相互作用。
Microbiome. 2024 Dec 20;12(1):267. doi: 10.1186/s40168-024-01970-2.
公共人类微生物组数据主要由高度发达的国家主导。
PLoS Biol. 2022 Feb 15;20(2):e3001536. doi: 10.1371/journal.pbio.3001536. eCollection 2022 Feb.
4
Digital twins for predictive oncology will be a paradigm shift for precision cancer care.用于肿瘤预测的数字孪生将成为精准癌症治疗的范式转变。
Nat Med. 2021 Dec;27(12):2065-2066. doi: 10.1038/s41591-021-01558-5.
5
Individualized therapy trials: navigating patient care, research goals and ethics.个体化治疗试验:兼顾患者护理、研究目标和伦理学。
Nat Med. 2021 Oct;27(10):1679-1686. doi: 10.1038/s41591-021-01519-y. Epub 2021 Oct 12.
6
Advancing Equity and Inclusion in Microbiome Research and Training.促进微生物组研究与培训中的公平与包容。
mSystems. 2021 Oct 26;6(5):e0115121. doi: 10.1128/mSystems.01151-21. Epub 2021 Oct 12.
7
Baseline Gut Metagenomic Functional Gene Signature Associated with Variable Weight Loss Responses following a Healthy Lifestyle Intervention in Humans.与人类健康生活方式干预后体重减轻反应差异相关的基线肠道宏基因组功能基因特征
mSystems. 2021 Oct 26;6(5):e0096421. doi: 10.1128/mSystems.00964-21. Epub 2021 Sep 14.
8
Gut Microbiota-Informed Precision Nutrition in the Generally Healthy Individual: Are We There Yet?一般健康个体中基于肠道微生物群的精准营养:我们做到了吗?
Curr Dev Nutr. 2021 Aug 9;5(9):nzab107. doi: 10.1093/cdn/nzab107. eCollection 2021 Sep.
9
Organ-on-Chip Approaches for Intestinal 3D In Vitro Modeling.器官芯片在肠道 3D 体外建模中的应用。
Cell Mol Gastroenterol Hepatol. 2022;13(2):351-367. doi: 10.1016/j.jcmgh.2021.08.015. Epub 2021 Aug 25.
10
Genome-Scale Metabolic Modeling of the Human Microbiome in the Era of Personalized Medicine.个性化医疗时代人类微生物组的全基因组规模代谢建模
Annu Rev Microbiol. 2021 Oct 8;75:199-222. doi: 10.1146/annurev-micro-060221-012134. Epub 2021 Jul 27.